A large-scale genetic analysis has revealed that reducing levels of specific Homer1 gene variants in mice improves attention by quieting brain activity. The research, published in Nature Neuroscience, suggests this approach could lead to novel treatments for ADHD and related disorders. The effect is most pronounced during a critical developmental period in adolescence.
Researchers at Rockefeller University conducted a comprehensive genetic study involving nearly 200 mice from eight diverse parental strains to explore the underpinnings of attention. Published in Nature Neuroscience, the work pinpointed the Homer1 gene as a key regulator, with lower levels of its variants Homer1a and Ania3 in the prefrontal cortex linked to superior performance on focus-demanding tasks.
The study, led by Priya Rajasethupathy and PhD student Zachary Gershon, analyzed genetic diversity to uncover subtle influences on attention. Mice excelling in behavioral tests showed reduced Homer1 expression, accounting for nearly 20 percent of attention variation—a notably large effect. "[That's] a huge effect," Rajasethupathy noted. "Even accounting for any overestimation... that's a remarkable number. Most of the time, you're lucky if you find a gene that affects even 1 percent of a trait."
Experimental reduction of Homer1a and Ania3 during adolescence enhanced speed, accuracy, and resistance to distractions in mice, but had no impact in adults, highlighting a narrow developmental window. At the cellular level, this led to increased GABA receptors, which dampen unnecessary neural firing while preserving responses to relevant stimuli. "We were sure that the more attentive mice would have more activity in the prefrontal cortex, not less," Rajasethupathy explained. "But it made some sense. Attention is, in part, about blocking everything else out."
Gershon, who has ADHD, connected the findings to personal experience: "It's part of my story, and one of the inspirations for me wanting to apply genetic mapping to attention." He observed parallels with practices like meditation that calm the nervous system for better focus.
The discovery challenges stimulant-based ADHD treatments by proposing therapies that reduce neural noise. Homer1's links to autism and schizophrenia broaden its implications. Future work may target a splice site in Homer1 pharmacologically to mimic meditation's quieting effect, as Rajasethupathy suggested: "This offers a tangible path toward creating a medication that has a similar quieting effect as meditation."
